- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Bilkent University - Anticancer Biomolecule Screening Core
Bilkent University - Anticancer Biomolecule Screening Core is listed as an academic core research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Academic core
No service areas are recorded for this supplier yet.
Where it operates
Sites by country, with the cities in each.
-
Turkiye 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
BILGEN in vitro anticancer biomolecule screening service aims to identify novel biologically active molecules that can be considered as candidate anti-cancer drugs. Our service is operational since the beginning of 2007. Our facility served to many centers in Turkey (Hacettepe University, Ankara University, Ataturk University) and abroad (École nationale supérieure de chimie de Paris). So far we screened up to 700 synthetic or natural plant originated compounds for their potential cytotoxic anticancer activity. For this purpose we made 42000 experiments. In our initial screening procedure...
Show the full description
BILGEN in vitro anticancer biomolecule screening service aims to identify novel biologically active molecules that can be considered as candidate anti-cancer drugs. Our service is operational since the beginning of 2007. Our facility served to many centers in Turkey (Hacettepe University, Ankara University, Ataturk University) and abroad (École nationale supérieure de chimie de Paris). So far we screened up to 700 synthetic or natural plant originated compounds for their potential cytotoxic anticancer activity. For this purpose we made 42000 experiments. In our initial screening procedure we use 3 human tumor cell lines (liver carcinoma Huh7, breast carcinoma T47-D and colon carcinoma HCT116). After the detection of an activity, further cell lines are tested. Dose response curve for each compound can be determined along with IC50 values. Our Screening methodology is based on NCI-SRB assay (Shoemaker, R. H. The NCI60 Human Tumour Cell line Anticancer Drug Screen.
Work with Bilkent University - Anticancer Biomolecule Screening Core on Scientist.com
For prices, more details, or to contact Bilkent University - Anticancer Biomolecule Screening Core, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.